KLRS

Kalaris Therapeutics

76 hedge funds and large institutions have $36.4M invested in Kalaris Therapeutics in 2024 Q1 according to their latest regulatory filings, with 12 funds opening new positions, 21 increasing their positions, 28 reducing their positions, and 17 closing their positions.

New
Increased
Maintained
Reduced
Closed

more call options, than puts

Call options by funds: $ | Put options by funds: $

more capital invested

Capital invested by funds: $ → $

more ownership

Funds ownership:

less funds holding

Funds holding:

25% less repeat investments, than reductions

Existing positions increased: 21 | Existing positions reduced: 28

29% less first-time investments, than exits

New positions opened: 12 | Existing positions closed: 17

Holders
76
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
$401K
Puts
$2K
Net Calls
Net Calls Change

Top Sellers

1 -$4.09M
2 -$2.57M
3 -$1.71M
4
Millennium Management
Millennium Management
New York
-$726K
5
Morgan Stanley
Morgan Stanley
New York
-$507K
Name Holding Trade Value Shares
Change
Change in
Stake
1
$8.53M
2
$4.98M
3
$3.17M
4
$2.56M
5
$2.22M
6
$2.21M
7
$1.95M
8
$1.44M
9
$1.2M
10
$962K
11
$889K
12
$740K
13
$657K
14
$650K
15
$348K
16
$339K
17
$274K
18
$267K
19
$240K
20
$225K
21
$205K
22
$171K
23
$163K
24
$154K
25
$151K